E
Dermata Therapeutics, Inc. DRMA
$5.50 -$0.33-5.66% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 26.15% 26.89% 0.70% -12.16% 9.74%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 5.38% 24.83% 41.90% 7.14% -96.66%
Change in Net Operating Assets -409.54% 60.14% 177.77% -139.03% 534.24%
Cash from Operations -39.11% 33.62% 14.78% -60.81% 21.39%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- 88.60% --
Repurchase of Common Stock -- -- -- 100.00% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- 200.00% --
Cash from Financing -106.45% 12,478.72% -101.49% 97.30% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -149.38% 319.89% -349.20% 460.78% 107.89%